SEO URLwww.firestrike.ai/deals/ventyx-biosciences-inc-lilly-acquisition-2026
acquisitionAnnounced · Jan 7, 2026BiotechnologySource · CredibleArticle · Factual
Lilly acquires Ventyx Biosciences Inc.
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$1B
Target
Ventyx Biosciences Inc.
Acquirer
Lilly
Full Acquisition
Status
Pending
Lilly agreed to acquire Ventyx Biosciences Inc.. Reported deal value: $1B. Status: Pending. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
Co. is in advanced talks to acquire Ventyx Biosciences Inc. for more than $1 billion to expand its work in immunology, according to a report in the Wall Street Journal
Deal timeline
Announced
Jan 7, 2026 · news.bloomberglaw.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $1B. Figures and status may change as sources update.
Sources: news.bloomberglaw.com · Primary article · FireStrike proprietary index